Infections are still a major reason of morbidity and one of the most common causes of death after hematopoietic cell transplantation (HCT). Antimicrobial prophylaxis plays a crucial role in decreasing non-relapse mortality after HCT. The objective of this guideline paper is presentation of current recommendations of antimicrobial prophylaxis for children and adults after hematopoietic cell transplantation, prepared in cooperation of Polish scientific hematological societies. Recommendations were prepared by the working group and finally approved by all 23 Polish transplant centers for children and adults. Existing ECIL (European Conference on Infections in Leukemia) and EBMT (European Society of Blood and Marrow Transplantation) guidelines,...
Invasive fungal disease (IFD) is one of the most serious complications of therapy in patients with i...
Patients after hematopoietic stem cell transplantation are a risk group for developing various compl...
Antifungal prophylaxis in adult stem cell transplantation and haematological malignanc
Infections are still a major reason of morbidity and one of the most common causes of death after he...
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophyla...
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophyla...
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophyla...
Abstract Specific protocols define eligibility, conditioning, donor selection, graft composition an...
The European Conference on Infections in Leukaemia (ECIL) updated its guidelines on antifungal proph...
Infectious complications represent one of the most common causes of morbidity and mortality in allog...
BACKGROUND: Bacteremia and other invasive bacterial infections are common among children with cancer...
AbstractCDC, the Infectious Diseases Society of America, and the American Society of Blood and Marro...
PURPOSE To develop a clinical practice guideline for systemic antifungal prophylaxis in pediatric pa...
Paediatric patients with cancer and those undergoing haematopoietic cell transplantation are at high...
Immunocompromised children and adolescents receiving treatment for cancer have an increased risk for...
Invasive fungal disease (IFD) is one of the most serious complications of therapy in patients with i...
Patients after hematopoietic stem cell transplantation are a risk group for developing various compl...
Antifungal prophylaxis in adult stem cell transplantation and haematological malignanc
Infections are still a major reason of morbidity and one of the most common causes of death after he...
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophyla...
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophyla...
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophyla...
Abstract Specific protocols define eligibility, conditioning, donor selection, graft composition an...
The European Conference on Infections in Leukaemia (ECIL) updated its guidelines on antifungal proph...
Infectious complications represent one of the most common causes of morbidity and mortality in allog...
BACKGROUND: Bacteremia and other invasive bacterial infections are common among children with cancer...
AbstractCDC, the Infectious Diseases Society of America, and the American Society of Blood and Marro...
PURPOSE To develop a clinical practice guideline for systemic antifungal prophylaxis in pediatric pa...
Paediatric patients with cancer and those undergoing haematopoietic cell transplantation are at high...
Immunocompromised children and adolescents receiving treatment for cancer have an increased risk for...
Invasive fungal disease (IFD) is one of the most serious complications of therapy in patients with i...
Patients after hematopoietic stem cell transplantation are a risk group for developing various compl...
Antifungal prophylaxis in adult stem cell transplantation and haematological malignanc